XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2021
Segment Reporting [Abstract]  
Reportable Segment Information
 Three Months EndedSix Months Ended
June 30,June 30,
(DOLLARS IN MILLIONS)2021202020212020
Net sales:
Nourish$1,668 $690 $2,976 $1,462 
Health & Biosciences639 34 1,065 68 
Scent550 475 1,119 1,016 
Pharma Solutions232 — 394 — 
Consolidated$3,089 $1,199 $5,554 $2,546 
Segment Adjusted Operating EBITDA
Nourish$324 $142 $594 $318 
Health & Biosciences190 10 318 19 
Scent117 87 245 205 
Pharma Solutions48 — 91 — 
Total679 239 1,248 542 
Depreciation & Amortization(322)(80)(564)(161)
Interest Expense(77)(32)(142)(64)
Other income, net11 16 18 
Frutarom Integration Related Costs (a)(1)(3)(2)(7)
Restructuring and Other Charges (24)(2)(28)(7)
Losses on sale of assets — — — (1)
Shareholder Activism Related Costs (b)— — (7)— 
Business Divestiture Costs (c)(5)— (5)— 
Employee Separation Costs (d)(3)— (6)— 
Compliance Review & Legal Defense Costs (e)— — — (1)
N&B Inventory Step-Up Costs (195)— (377)— 
N&B Transaction Related Costs (f)(2)(11)(91)(16)
N&B Integration Related Costs (g)(17)(23)(54)(33)
Income (Loss) Before Taxes$44 $104 $(10)$257 
_______________________
(a)Represents costs related to the integration of the Frutarom acquisition. For 2021, costs primarily related to performance stock awards. For 2020, costs primarily related to advisory services, retention bonuses and performance stock awards.
(b)Represents shareholder activist related costs, primarily professional fees.
(c)Represents costs related to the Company's planned sales of businesses, primarily includes legal and professional fees.
(d)Represents costs related to severance liabilities, including accelerated stock compensation expense, for employees who have been separated from the Company.
(e)Costs related to reviewing the nature of inappropriate payments and review of compliance in certain other countries. In addition, includes legal costs for related shareholder lawsuits.
(f)Represents transaction costs and expenses related to the transaction with N&B, primarily includes legal and professional fees.
(g)Represents costs primarily related to advisory services for the integration of the transaction with N&B, primarily consulting fees.
Net Sales by Destination of Product Delivery
Net sales, which are attributed to individual regions based upon the destination of product delivery, were as follows:
 Three Months Ended June 30,Six Months Ended June 30,
(DOLLARS IN MILLIONS)2021202020212020
Europe, Africa and Middle East$1,084 $463 $1,957 $1,006 
Greater Asia707 275 1,294 585 
North America961 301 1,683 604 
Latin America337 160 620 351 
Consolidated$3,089 $1,199 $5,554 $2,546 
 Three Months Ended June 30,Six Months Ended June 30,
(DOLLARS IN MILLIONS)2021202020212020
Net sales related to the U.S.$876 $268 $1,530 $539 
Net sales attributed to all foreign countries2,213 931 4,024 2,007